Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients

NCT04148001 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2021-02-02

No results posted yet for this study

Summary

This study is designed to help identify patients with HoFH due to mutations in the LDLR as confirmed by genotyping.

Conditions

  • Homozygous Familial Hypercholesterolemia (HoFH)

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-04
Primary Completion
2020-04-08
Completion
2020-04-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04148001 on ClinicalTrials.gov